News.

Nov 10, 2025
elecell Awarded the 2025 Digital Innovation<br>Award by The Korea Times
Breakthrough self-powered bioelectric patch technology recognized as a next-generation medical innovation SEOUL, South Korea — 2025

Oct 2, 2025
Game-Changer at
MEDevice Boston:
elecell Unveiled the World’s First Self-Powered
Chronic Wound Patch
Boston, MA — September 30, 2025 — elecell, a medical device company pioneering accessible chronic wound care innovation, announced today its self-powered chronic wound healing patch at the MEDevice Boston. This marks a significant leap forward in wound management, as the device requires no external power source to accelerate healing.

Jul 30, 2025
elecell Inc. Selected as One of Fortune Korea's Top 40 Korean Healthcare Innovators
elecell Inc. Selected as One of Fortune Korea's Top 40 Korean Healthcare Innovators

Apr 21, 2025
The Chosun Ilbo (Science Chosun, Chosun Biz) featured eleccell Co., Ltd. as a frontier technology innovator in the pharmaceutical and biotechnology sector
The Chosun Ilbo (Science Chosun, Chosun Biz) featured eleccell Co., Ltd. as a frontier technology innovator in the pharmaceutical and biotechnology sector

Let's talk .
Through this partnership, we can advance biomimetic current-based tissue regeneration and wound healing technologies and share groundbreaking solutions. Learn more about our partnership with Eleccell and join us as we strive to bring the world's first next-generation treatments to market.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.
Let's talk.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.